GO
Loading...

Currencies

Major Currency Pairs

  Price   Change %Change
EUR/USD
---
USD/JPY
---
GBP/USD
---
USD/CAD
---
USD/CHF
---
AUD/USD
---
EUR/CHF
---
EUR/GBP
---
EUR/JPY
---
AUD/JPY
---

Americas

  Price   Change %Change
USD/MXN
---
USD/BRL
---
USD/ARS
---
USD/COP
---
USD/CLP
---

Asia-Pacific

  Price   Change %Change
NZD/USD
---
USD/SGD
---
USD/HKD
---
USD/KRW
---
USD/INR
---

Europe

  Price   Change %Change
USD/SEK
---
USD/NOK
---
USD/RUB
---
USD/DKK
---
USD/PLN
---

Contact Currencies

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

CURRENCIES

  Price   Change %Change
EUR/USD
---
USD/JPY
---
GBP/USD
---
USD/CHF
---
USD/CAD
---

Most Popular Video

Wednesday, 23 Apr 2014 | 7:33 AM ET

J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, explains why he decided to pursue Allergan and shares his R&D business model, with CNBC's Kate Kelly. This year we are launching 19 products in the United States, says Pearson.

Wednesday, 23 Apr 2014 | 6:13 AM ET

Chris Caso, Susquehanna Financial Group analyst, shares his outlook on Apple in the second half. Apple needs to show shareholders the next new thing, says Caso.

Wednesday, 23 Apr 2014 | 4:10 AM ET

Fraser Howie, director at Newedge Singapore, says the PMI data reveals China is "in a bit of a rut" and that the government has a "horrible problem" as it can't bring out too much stimulus.